mSphere (Apr 2021)
Comparative Study of the Susceptibility to Oxidative Stress between Two Types of Mycobacterium bovis BCG Tokyo 172
- Keiichi Taniguchi,
- Daisuke Hayashi,
- Naomi Yasuda,
- Mao Nakayama,
- Kaori Yazawa,
- Shouta Ogawa,
- Yuji Miyatake,
- Saki Suda,
- Haruka Tomita,
- Miki Tokuda,
- Saotomo Itoh,
- Jun-ichi Maeyama,
- Naoya Ohara,
- Saburo Yamamoto,
- Shigeaki Hida,
- Kikuo Onozaki,
- Takemasa Takii
Affiliations
- Keiichi Taniguchi
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Daisuke Hayashi
- Japan BCG Laboratory, Kiyose, Tokyo, Japan
- Naomi Yasuda
- Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan
- Mao Nakayama
- Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan
- Kaori Yazawa
- Department of Mycobacterium Reference and Research, Research Institute of Tuberculosis, Japan Anti-Tuberculosis Association, Kiyose, Tokyo, Japan
- Shouta Ogawa
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Yuji Miyatake
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Saki Suda
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Haruka Tomita
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Miki Tokuda
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Saotomo Itoh
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Jun-ichi Maeyama
- Department of Safety Research on Blood and Biological Products, National Institute of Infectious Diseases, Musashimurayama, Tokyo, Japan
- Naoya Ohara
- Department of Oral Microbiology, Graduated School of Medicine, Dentistry and Pharmaceutical Sciences, Okayama University, Okayama, Japan
- Saburo Yamamoto
- Japan BCG Laboratory, Kiyose, Tokyo, Japan
- Shigeaki Hida
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Kikuo Onozaki
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- Takemasa Takii
- ORCiD
- Department of Molecular Health Sciences, Graduated School of Pharmaceutical Sciences, Nagoya City University, Nagoya, Aichi, Japan
- DOI
- https://doi.org/10.1128/mSphere.00111-21
- Journal volume & issue
-
Vol. 6,
no. 2
Abstract
This study revealed the difference of in vivoin vitro
